Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29773593

Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Haematologica
Publication date
2018 Aug
First author
Gambacorti-Passerini C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Gambacorti-Passerini C
      type
      Author
    2. name
      Cortes JE
      type
      Author
    3. name
      Lipton JH
      type
      Author
    4. name
      Kantarjian HM
      type
      Author
    5. name
      Kim DW
      type
      Author
    6. name
      Schafhausen P
      type
      Author
    7. name
      Crescenzo R
      type
      Author
    8. name
      Bardy-Bouxin N
      type
      Author
    9. name
      Shapiro M
      type
      Author
    10. name
      Noonan K
      type
      Author
    11. name
      Leip E
      type
      Author
    12. name
      DeAnnuntis L
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Gambacorti-Passerini C
      type
      Author
    2. name
      Cortes JE
      type
      Author
    3. name
      Lipton JH
      type
      Author
    4. name
      Kantarjian HM
      type
      Author
    5. name
      Kim DW
      type
      Author
    6. name
      Schafhausen P
      type
      Author
    7. name
      Crescenzo R
      type
      Author
    8. name
      Bardy-Bouxin N
      type
      Author
    9. name
      Shapiro M
      type
      Author
    10. name
      Noonan K
      type
      Author
    11. name
      Leip E
      type
      Author
    12. name
      DeAnnuntis L
      type
      Author
    bibliography ids
    1. nci-bib-7f444f9a0f121862548b5e96
    book metadata
    content sha256
    be275eca482724817612f44a7b025ad65edda3027c8e3f25a979cdaef88e26aa
    document type
    citation
    dois
    1. 10.3324/haematol.2017.171249
    electronic publication date
    display
    2018 May 17
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29773593
    immutable id
    pubmed:29773593@be275eca482724817612f44a7b025ad65edda3027c8e3f25a979cdaef88e26aa
    journal
    abbreviation
    Haematologica
    issn electronic
    1592-8721
    issn print
    0390-6078
    issue
    8
    name
    Haematologica
    nlm unique id
    0417435
    pages
    1298-1307
    volume
    103
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29773593
      provenance
      batch id
      c4c0356d060413f719c2
      provider
      NCBI PubMed ESummary
      record sha256
      0ff75309fa90f4e29dece32eb7874f9c05ae97a65aefb95237a9ce632b415784
      response sha256
      adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
      retrieved at
      2026-09-09T23:47:33.674758+00:00
      publication date
      display
      2018 Aug
      precision
      month
      year
      2018
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, N.I.H., Extramural
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29773593/
      title
      Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study.

      Preserved source evidence · Not medical advice